EB Resnet is a network of EB patient organisations actively involved in funding and managing EB research and building bridges to clinical translation.

We support world-class research, worldwide, to increase understanding of the causes and consequences of Epidermolysis Bullosa (EB), and to develop the evidence base for the development of better clinical care, diagnostics, and disease-modifying therapies for those with EB. The network is resourced through its member organisations and partners.

The overall objective: Find a cure and therapies for people living with Epidermolysis Bullosa. 

Please check the deadlines for submission carefully. When preparing your application via our online system Grant Tracker, please allow enough time before submission to verify that all signatories have given their approval, as requested by the system. Incomplete applications will not be accepted.

Make sure to update your bookmark as the former link has changed.